New ADS advice on how to manage DKA with SGLT2 inhibitors

Several changes have been made and new information added to updated advice from the Australian Diabetes Society on the management of diabetic ketoacidosis (DKA) with SGLT2 inhibitor. In an alert update, the ADS has issued new recommendations including: Blood testing is now strongly recommended to be used in detecting and monitoring DKA as urine ketone ...

Already a member?

Login to keep reading.

© 2021 the limbic